In the present study, CDT is paired with STING pathway activation in a drug-loaded hydrogel-carrying system to effectively destroy tumor cells and restructure immunosuppressive TME to trigger anti-tumor immunity 81. The gene discussed is STING1; the disease is neoplasm.